TILS.L Share News (TILS)
TILS Share
TILS Share
TILS Share
TILS Share
TILS
TILS Share
TILS Broker
TILS Directors
TILS Financial
TILS
TILS Short
TILSThu, 18th Jun 2020 18:30
Tiziana Life Sciences PLC - London-based oncology and immunology treatments - Gregor MacRae steps down as director with immediate effect. Says looking for new non-executive director with Nasdaq audit committee experience.
Current stock price: 90.00 pence
Year-to-date change: up more than 100%, 41.00p on January 2
By Tom Waite; thomaslwaite@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
UK TRADING UPDATE SUMMARY: Tiziana Offering to Raise GBP57 Million
Read moreIN BRIEF: Tiziana Submits Covid-19 Patent Application For Foralumab
Read moreIN BRIEF: Tiziana Bolsters Board By Adding John Brancaccio
Read moreUK TRADING UPDATE SUMMARY: LoopUp Set To Beat Expectations For 2020
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreIN BRIEF: Tiziana Life Sciences Progressing On StemPrintER Demerger
Read moreIN BRIEF: Tiziana Seals Manufacturing Agreement With STC Biologics
Read moreUK WINNERS & LOSERS SUMMARY: TomCo Shares Double As It Cancels Placing
Read moreTiziana Granted US Patent For Oral Administration Of Foralumab
Read moreTiziana Annual Loss Widens On Higher Costs, Outlines Busy 2020
Read more
(Sharecast News) - Tiziana Life Sciences announced an extension to the current 'at the market sales agreement' with ThinkEquity, a division of Fordham Financial Management, on Friday.
Read moreUK TRADING UPDATE SUMMARY: Catenae Inks Pilot Pact For Cov-ID App
Read moreUK Shareholder Meetings Calendar - Next 7 Days
Read moreTiziana Life Sciences Files Patent For Coronavirus Treatment
Read more